Evidence map›Paper›PMID 34233591›Full record

ArticleBioengineered2021

Identification and validation of the miRNA-mRNA regulatory network in fetoplacental arterial endothelial cells of gestational diabetes mellitus.

Longkai He, Xiaotong Wang, Ya Jin, Weipeng Xu, Yi Guan, Jingchao Wu, Shasha Han, Guosheng Liu

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. The role of microRNAs in pregnancies complicated by maternal diabetes.Clinical science (London, England : 1979) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Longkai HeDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Xiaotong WangDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Ya JinDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Weipeng XuDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Yi GuanDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Jingchao WuDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Shasha HanDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Guosheng LiuDepartment of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
First Affiliated Hospital of Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) increases the risk of fetal heart malformations, though little is known about the mechanism of hyperglycemia-induced heart malformations. Thus, we aimed to reveal the global landscape of miRNAs and mRNAs in GDM-exposed fetoplacental arterial endothelial cells (dAECs) and establish regulatory networks for exploring the pathophysiological mechanism of fetal heart malformations in maternal hyperglycemia. Gene Expression Omnibus (GEO) datasets were used, and identification of differentially expressed miRNAs (DEMs) and genes (DEGs) in GDM was based on a previous sequencing analysis of dAECs. A miRNA-mRNA network containing 20 DEMs and 65 DEGs was established using DEMs altered in opposite directions to DEGs. In an in vivo study, we established a streptozotocin-induced pregestational diabetes mellitus (PGDM) mouse model and found the fetal cardiac wall thickness in different regions to be dramatically increased in the PGDM grouValidation of DEMs and DEGs in the fetal heart showed significantly upregulated expression of let-7e-5p, miR-139-5p and miR-195-5p and downregulated expression of SGOL1, RRM2, RGS5, CDK1 and CENPA. In summary, we reveal the miRNA-mRNA regulatory network related to fetal cardiac development disorders in offspring, which may shed light on the potential molecular mechanisms of fetal cardiac development disorders during maternal hyperglycemia.

Indexed as

Endothelial CellsAnimalsCells, CulturedDatabases, GeneticDiabetes, GestationalFemaleFetusHumansMiceMice, Inbred C57BLMicroRNAsPlacentaPregnancyRNA, MessengerTranscriptomeMicroRNAsRNA, Messengerbioinformatics analysiscardiac hypertrophyfetoplacental endothelial cellsgestational diabetes mellitusheart developmentMirna-mRNA network

Identifiers

PMID34233591
PMCPMC8806558
OpenAlexW3178377200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.